Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22007715 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa
Condition: Malaria
Interventions: Biological: Malaria Vaccine 257049;   Biological: Meningococcal C Conjugate Vaccine;   Biological: Cell-culture rabies vaccine;   Biological: TritanrixHepB/Hib;   Biological: Polio Sabin Oral Polio Vaccine (GSK)
2 Recruiting A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
Condition: Malaria
Interventions: Biological: R21/Matrix-M1;   Other: Saline

Study has passed its completion date and status has not been verified in more than two years.